Atlas Biomed

News

A UK-based company offering DNA and microbiome tests directly to consumers has expanded its services to 10 more European countries.

News

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.